Mednax Inc Stock Performance
| MD Stock | USD 14.08 0.16 1.12% |
The company secures a Beta (Market Risk) of 0.92, which conveys possible diversification benefits within a given portfolio. Mednax returns are very sensitive to returns on the market. As the market goes up or down, Mednax is expected to follow. Mednax Inc right now secures a risk of 3.74%. Please verify Mednax Inc information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis , to decide if Mednax Inc will be following its current price movements.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days Mednax Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Mednax is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (1.12) | Five Day Return 1.29 | Year To Date Return 8.06 | Ten Year Return (80.46) | All Time Return 163.49 |
Last Split Factor 2:1 | Last Split Date 2013-12-20 |
1 | Acquisition by Mark Ordan of 640000 shares of Mednax subject to Rule 16b-3 | 01/10/2025 |
2 | Pediatrix Medical Group 2024 Fourth Quarter Conference CallWebcast Scheduled for Thursday, February 20, 2025 | 02/10/2025 |
3 | These 4 Measures Indicate That Pediatrix Medical Group Is Using Debt Extensively | 02/18/2025 |
4 | Pediatrix Medical Group Shares Gap Up on Earnings Beat | 02/20/2025 |
5 | Pediatrix Medical Group, Inc. Q4 2024 Earnings Call Transcript | 02/21/2025 |
6 | Disposition of 17668 shares by Shirley Weis of Mednax subject to Rule 16b-3 | 02/25/2025 |
7 | Disposition of 3718 shares by Kasandra Rossi of Mednax at 14.77 subject to Rule 16b-3 | 02/28/2025 |
8 | Pediatrix Medical Group, Inc. Stake Lessened by Clark Estates Inc. NY | 03/05/2025 |
9 | Disposition of 26497 shares by Mary Moore of Mednax subject to Rule 16b-3 | 03/06/2025 |
10 | Why Are Institutional Investors Adjusting Their Holdings in Pediatrix Medical Group, Inc. | 03/17/2025 |
| Begin Period Cash Flow | 73.3 M |
Mednax |
Mednax Relative Risk vs. Return Landscape
If you would invest 1,425 in Mednax Inc on December 19, 2024 and sell it today you would lose (17.00) from holding Mednax Inc or give up 1.19% of portfolio value over 90 days. Mednax Inc is generating 0.0434% of daily returns and assumes 3.738% volatility on return distribution over the 90 days horizon. Put differently, 33% of stocks are less risky than Mednax on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Mednax Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mednax's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mednax Inc, and traders can use it to determine the average amount a Mednax's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0116
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MD |
Estimated Market Risk
| 3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mednax is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mednax by adding Mednax to a well-diversified portfolio.
Mednax Fundamentals Growth
Mednax Stock prices reflect investors' perceptions of the future prospects and financial health of Mednax, and Mednax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mednax Stock performance.
| Return On Equity | -0.12 | ||||
| Return On Asset | 0.0525 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 1.49 B | ||||
| Shares Outstanding | 85.83 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 1.54 X | ||||
| Price To Sales | 0.61 X | ||||
| Revenue | 2.01 B | ||||
| Gross Profit | 454.34 M | ||||
| EBITDA | (28.37 M) | ||||
| Net Income | (99.07 M) | ||||
| Cash And Equivalents | 9.82 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 662.31 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 9.09 X | ||||
| Cash Flow From Operations | 206.57 M | ||||
| Earnings Per Share | (1.19) X | ||||
| Market Capitalization | 1.22 B | ||||
| Total Asset | 2.15 B | ||||
| Retained Earnings | (248.54 M) | ||||
| Working Capital | 205.5 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
About Mednax Performance
By analyzing Mednax's fundamental ratios, stakeholders can gain valuable insights into Mednax's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mednax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mednax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.12) | (0.11) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.14) | (0.13) |
Things to note about Mednax Inc performance evaluation
Checking the ongoing alerts about Mednax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mednax Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mednax Inc had very high historical volatility over the last 90 days | |
| The company generated the yearly revenue of 2.01 B. Annual Net Loss to common stockholders was (99.07 M) with gross profit of 454.34 M. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from kalkinemedia.com: Why Are Institutional Investors Adjusting Their Holdings in Pediatrix Medical Group, Inc. |
- Analyzing Mednax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mednax's stock is overvalued or undervalued compared to its peers.
- Examining Mednax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mednax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mednax's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mednax's stock. These opinions can provide insight into Mednax's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |